nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirabegron—BCHE—malignant glioma	0.883	1	CbGaD
Mirabegron—CYP3A4—Temozolomide—malignant glioma	0.0285	1	CbGbCtD
Mirabegron—ORM1—vertebral column—malignant glioma	0.0034	0.264	CbGeAlD
Mirabegron—Gamma-glutamyltransferase increased—Temozolomide—malignant glioma	0.00192	0.0408	CcSEcCtD
Mirabegron—Vaginal infection—Temozolomide—malignant glioma	0.00149	0.0317	CcSEcCtD
Mirabegron—Neoplasm—Carmustine—malignant glioma	0.00147	0.0314	CcSEcCtD
Mirabegron—Dry eye—Temozolomide—malignant glioma	0.00146	0.031	CcSEcCtD
Mirabegron—Neoplasm—Temozolomide—malignant glioma	0.00142	0.0304	CcSEcCtD
Mirabegron—Vascular purpura—Temozolomide—malignant glioma	0.00128	0.0273	CcSEcCtD
Mirabegron—Purpura—Temozolomide—malignant glioma	0.00119	0.0253	CcSEcCtD
Mirabegron—Breast disorder—Temozolomide—malignant glioma	0.00103	0.022	CcSEcCtD
Mirabegron—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00103	0.022	CcSEcCtD
Mirabegron—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00101	0.0215	CcSEcCtD
Mirabegron—Abdominal distension—Temozolomide—malignant glioma	0.000995	0.0212	CcSEcCtD
Mirabegron—Upper respiratory tract infection—Temozolomide—malignant glioma	0.000919	0.0196	CcSEcCtD
Mirabegron—Urinary tract infection—Carmustine—malignant glioma	0.000887	0.0189	CcSEcCtD
Mirabegron—Infestation—Temozolomide—malignant glioma	0.000881	0.0188	CcSEcCtD
Mirabegron—Infestation NOS—Temozolomide—malignant glioma	0.000881	0.0188	CcSEcCtD
Mirabegron—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.000874	0.0186	CcSEcCtD
Mirabegron—Urinary tract infection—Temozolomide—malignant glioma	0.000857	0.0183	CcSEcCtD
Mirabegron—Sinusitis—Temozolomide—malignant glioma	0.000827	0.0176	CcSEcCtD
Mirabegron—Connective tissue disorder—Carmustine—malignant glioma	0.000805	0.0172	CcSEcCtD
Mirabegron—Urinary tract disorder—Temozolomide—malignant glioma	0.000781	0.0167	CcSEcCtD
Mirabegron—Connective tissue disorder—Temozolomide—malignant glioma	0.000778	0.0166	CcSEcCtD
Mirabegron—Urethral disorder—Temozolomide—malignant glioma	0.000776	0.0165	CcSEcCtD
Mirabegron—Eye disorder—Carmustine—malignant glioma	0.000765	0.0163	CcSEcCtD
Mirabegron—Erythema multiforme—Temozolomide—malignant glioma	0.000748	0.016	CcSEcCtD
Mirabegron—Eye disorder—Temozolomide—malignant glioma	0.000739	0.0158	CcSEcCtD
Mirabegron—Cardiac disorder—Temozolomide—malignant glioma	0.000734	0.0157	CcSEcCtD
Mirabegron—Back pain—Carmustine—malignant glioma	0.000689	0.0147	CcSEcCtD
Mirabegron—Vision blurred—Carmustine—malignant glioma	0.000672	0.0143	CcSEcCtD
Mirabegron—Back pain—Temozolomide—malignant glioma	0.000666	0.0142	CcSEcCtD
Mirabegron—Vision blurred—Temozolomide—malignant glioma	0.000649	0.0138	CcSEcCtD
Mirabegron—Hypertension—Carmustine—malignant glioma	0.000615	0.0131	CcSEcCtD
Mirabegron—Palpitations—Temozolomide—malignant glioma	0.000609	0.013	CcSEcCtD
Mirabegron—SLCO1A2—telencephalon—malignant glioma	0.000597	0.0463	CbGeAlD
Mirabegron—Hypertension—Temozolomide—malignant glioma	0.000595	0.0127	CcSEcCtD
Mirabegron—Arthralgia—Temozolomide—malignant glioma	0.000586	0.0125	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000582	0.0124	CcSEcCtD
Mirabegron—Infection—Carmustine—malignant glioma	0.000578	0.0123	CcSEcCtD
Mirabegron—Dry mouth—Temozolomide—malignant glioma	0.000574	0.0122	CcSEcCtD
Mirabegron—Tachycardia—Carmustine—malignant glioma	0.000568	0.0121	CcSEcCtD
Mirabegron—Infection—Temozolomide—malignant glioma	0.000558	0.0119	CcSEcCtD
Mirabegron—Skin disorder—Temozolomide—malignant glioma	0.000546	0.0116	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00053	0.0113	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000512	0.0109	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Carmustine—malignant glioma	0.000502	0.0107	CcSEcCtD
Mirabegron—Constipation—Carmustine—malignant glioma	0.000497	0.0106	CcSEcCtD
Mirabegron—Dyspepsia—Temozolomide—malignant glioma	0.000495	0.0106	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000485	0.0103	CcSEcCtD
Mirabegron—Fatigue—Temozolomide—malignant glioma	0.000485	0.0103	CcSEcCtD
Mirabegron—Constipation—Temozolomide—malignant glioma	0.000481	0.0103	CcSEcCtD
Mirabegron—Gastrointestinal pain—Carmustine—malignant glioma	0.000476	0.0101	CcSEcCtD
Mirabegron—ORM1—spinal cord—malignant glioma	0.000474	0.0368	CbGeAlD
Mirabegron—BCHE—brainstem—malignant glioma	0.000473	0.0367	CbGeAlD
Mirabegron—SLCO1A2—medulla oblongata—malignant glioma	0.000469	0.0364	CbGeAlD
Mirabegron—Abdominal pain—Carmustine—malignant glioma	0.00046	0.00981	CcSEcCtD
Mirabegron—Gastrointestinal pain—Temozolomide—malignant glioma	0.00046	0.0098	CcSEcCtD
Mirabegron—Urticaria—Temozolomide—malignant glioma	0.000447	0.00952	CcSEcCtD
Mirabegron—Abdominal pain—Temozolomide—malignant glioma	0.000444	0.00948	CcSEcCtD
Mirabegron—SLCO1A2—midbrain—malignant glioma	0.000429	0.0333	CbGeAlD
Mirabegron—BCHE—telencephalon—malignant glioma	0.00042	0.0326	CbGeAlD
Mirabegron—SLCO1A2—spinal cord—malignant glioma	0.000419	0.0325	CbGeAlD
Mirabegron—Asthenia—Carmustine—malignant glioma	0.000417	0.0089	CcSEcCtD
Mirabegron—ABCB1—blood vessel—malignant glioma	0.000412	0.032	CbGeAlD
Mirabegron—Asthenia—Temozolomide—malignant glioma	0.000403	0.0086	CcSEcCtD
Mirabegron—Diarrhoea—Carmustine—malignant glioma	0.000398	0.00849	CcSEcCtD
Mirabegron—Pruritus—Temozolomide—malignant glioma	0.000398	0.00848	CcSEcCtD
Mirabegron—ORM1—central nervous system—malignant glioma	0.000385	0.0299	CbGeAlD
Mirabegron—Dizziness—Carmustine—malignant glioma	0.000385	0.0082	CcSEcCtD
Mirabegron—Diarrhoea—Temozolomide—malignant glioma	0.000385	0.0082	CcSEcCtD
Mirabegron—Dizziness—Temozolomide—malignant glioma	0.000372	0.00793	CcSEcCtD
Mirabegron—Rash—Carmustine—malignant glioma	0.000367	0.00782	CcSEcCtD
Mirabegron—Dermatitis—Carmustine—malignant glioma	0.000366	0.00781	CcSEcCtD
Mirabegron—Headache—Carmustine—malignant glioma	0.000364	0.00777	CcSEcCtD
Mirabegron—Rash—Temozolomide—malignant glioma	0.000354	0.00756	CcSEcCtD
Mirabegron—Dermatitis—Temozolomide—malignant glioma	0.000354	0.00755	CcSEcCtD
Mirabegron—Headache—Temozolomide—malignant glioma	0.000352	0.00751	CcSEcCtD
Mirabegron—Nausea—Carmustine—malignant glioma	0.000346	0.00737	CcSEcCtD
Mirabegron—SLCO1A2—central nervous system—malignant glioma	0.00034	0.0263	CbGeAlD
Mirabegron—Nausea—Temozolomide—malignant glioma	0.000334	0.00712	CcSEcCtD
Mirabegron—SLCO1A2—cerebellum—malignant glioma	0.000332	0.0257	CbGeAlD
Mirabegron—BCHE—medulla oblongata—malignant glioma	0.00033	0.0256	CbGeAlD
Mirabegron—CYP2D6—brainstem—malignant glioma	0.000313	0.0243	CbGeAlD
Mirabegron—BCHE—midbrain—malignant glioma	0.000302	0.0234	CbGeAlD
Mirabegron—BCHE—spinal cord—malignant glioma	0.000294	0.0228	CbGeAlD
Mirabegron—CYP2D6—telencephalon—malignant glioma	0.000278	0.0216	CbGeAlD
Mirabegron—SLCO1A2—brain—malignant glioma	0.00027	0.0209	CbGeAlD
Mirabegron—ALB—brain—malignant glioma	0.000268	0.0208	CbGeAlD
Mirabegron—ABCB1—embryo—malignant glioma	0.000246	0.0191	CbGeAlD
Mirabegron—BCHE—central nervous system—malignant glioma	0.000239	0.0185	CbGeAlD
Mirabegron—BCHE—cerebellum—malignant glioma	0.000233	0.0181	CbGeAlD
Mirabegron—ABCB1—retina—malignant glioma	0.000218	0.0169	CbGeAlD
Mirabegron—ABCB1—telencephalon—malignant glioma	0.0002	0.0155	CbGeAlD
Mirabegron—BCHE—brain—malignant glioma	0.000189	0.0147	CbGeAlD
Mirabegron—CYP3A4—central nervous system—malignant glioma	0.000161	0.0125	CbGeAlD
Mirabegron—CYP2D6—central nervous system—malignant glioma	0.000158	0.0123	CbGeAlD
Mirabegron—ABCB1—medulla oblongata—malignant glioma	0.000157	0.0122	CbGeAlD
Mirabegron—CYP2D6—cerebellum—malignant glioma	0.000155	0.012	CbGeAlD
Mirabegron—ABCB1—midbrain—malignant glioma	0.000144	0.0111	CbGeAlD
Mirabegron—ABCB1—spinal cord—malignant glioma	0.00014	0.0109	CbGeAlD
Mirabegron—CYP2D6—brain—malignant glioma	0.000126	0.00974	CbGeAlD
Mirabegron—ABCB1—central nervous system—malignant glioma	0.000114	0.00882	CbGeAlD
Mirabegron—ABCB1—cerebellum—malignant glioma	0.000111	0.00863	CbGeAlD
Mirabegron—ABCB1—brain—malignant glioma	9.03e-05	0.00701	CbGeAlD
Mirabegron—ADRB3—GPCR downstream signaling—PIK3CD—malignant glioma	2.12e-05	0.000744	CbGpPWpGaD
Mirabegron—ALB—Transmembrane transport of small molecules—SLC5A5—malignant glioma	2.11e-05	0.000743	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—KNG1—malignant glioma	2.09e-05	0.000734	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—GSTT1—malignant glioma	2.06e-05	0.000726	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—BCHE—malignant glioma	2.05e-05	0.000721	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	2.05e-05	0.00072	CbGpPWpGaD
Mirabegron—ALB—Platelet activation, signaling and aggregation—RAF1—malignant glioma	2.04e-05	0.000718	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—SLC5A5—malignant glioma	2.02e-05	0.000712	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	2.02e-05	0.000709	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ASMT—malignant glioma	2.02e-05	0.000709	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—TFRC—malignant glioma	2.02e-05	0.000709	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—SOD1—malignant glioma	2.01e-05	0.000708	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	2.01e-05	0.000707	CbGpPWpGaD
Mirabegron—ALB—Transmembrane transport of small molecules—SLC6A3—malignant glioma	2.01e-05	0.000707	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—AKT2—malignant glioma	2e-05	0.000703	CbGpPWpGaD
Mirabegron—ALB—Platelet activation, signaling and aggregation—PIK3CB—malignant glioma	1.99e-05	0.000701	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—NTRK1—malignant glioma	1.99e-05	0.000699	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	1.99e-05	0.000699	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of proteins—F2—malignant glioma	1.98e-05	0.000696	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	1.94e-05	0.000684	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PTGS1—malignant glioma	1.93e-05	0.00068	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.93e-05	0.000678	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—PIK3CD—malignant glioma	1.92e-05	0.000676	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.91e-05	0.000673	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ASMT—malignant glioma	1.9e-05	0.000668	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.9e-05	0.000667	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—BCAN—malignant glioma	1.9e-05	0.000666	CbGpPWpGaD
Mirabegron—SLCO1A2—Transmembrane transport of small molecules—RAF1—malignant glioma	1.86e-05	0.000656	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	1.85e-05	0.000651	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—MMP3—malignant glioma	1.85e-05	0.00065	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—PTK2—malignant glioma	1.85e-05	0.00065	CbGpPWpGaD
Mirabegron—ADRB3—GPCR downstream signaling—PIK3CB—malignant glioma	1.84e-05	0.000648	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CDKN2B—malignant glioma	1.83e-05	0.000645	CbGpPWpGaD
Mirabegron—ALB—Platelet activation, signaling and aggregation—IL2—malignant glioma	1.83e-05	0.000644	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	1.81e-05	0.000635	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—BCAN—malignant glioma	1.79e-05	0.000628	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—PTK2—malignant glioma	1.78e-05	0.000626	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—SLC5A5—malignant glioma	1.78e-05	0.000625	CbGpPWpGaD
Mirabegron—ADRB3—GPCR downstream signaling—CXCL8—malignant glioma	1.77e-05	0.000623	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	1.76e-05	0.000619	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—HES1—malignant glioma	1.75e-05	0.000615	CbGpPWpGaD
Mirabegron—ALB—Metabolism—IDH2—malignant glioma	1.74e-05	0.000613	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—NCOR1—malignant glioma	1.74e-05	0.000611	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—RAF1—malignant glioma	1.72e-05	0.000603	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	1.7e-05	0.000596	CbGpPWpGaD
Mirabegron—ADRB3—GPCR downstream signaling—IL2—malignant glioma	1.69e-05	0.000595	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.68e-05	0.000591	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of proteins—MMP2—malignant glioma	1.68e-05	0.00059	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—PIK3CB—malignant glioma	1.67e-05	0.000589	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—PDGFRA—malignant glioma	1.66e-05	0.000585	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.66e-05	0.000585	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.65e-05	0.000582	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.64e-05	0.000578	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CYP2B6—malignant glioma	1.64e-05	0.000576	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—GSTP1—malignant glioma	1.63e-05	0.000573	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—SPP1—malignant glioma	1.62e-05	0.000568	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—CXCL8—malignant glioma	1.61e-05	0.000566	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—CAT—malignant glioma	1.59e-05	0.000558	CbGpPWpGaD
Mirabegron—ALB—Platelet activation, signaling and aggregation—VEGFA—malignant glioma	1.56e-05	0.000547	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—PDGFB—malignant glioma	1.55e-05	0.000546	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—IL2—malignant glioma	1.54e-05	0.000541	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—TERT—malignant glioma	1.53e-05	0.000539	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	1.53e-05	0.000539	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—IDH2—malignant glioma	1.53e-05	0.000537	CbGpPWpGaD
Mirabegron—ALB—Metabolism—IDH1—malignant glioma	1.5e-05	0.000527	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—NCOR1—malignant glioma	1.5e-05	0.000527	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—PDGFB—malignant glioma	1.5e-05	0.000526	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—FGFR1—malignant glioma	1.49e-05	0.000523	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—CAV1—malignant glioma	1.47e-05	0.000518	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—HIF1A—malignant glioma	1.47e-05	0.000515	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—COX8A—malignant glioma	1.46e-05	0.000514	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.45e-05	0.00051	CbGpPWpGaD
Mirabegron—ALB—Metabolism—SPHK1—malignant glioma	1.45e-05	0.00051	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—IDH2—malignant glioma	1.44e-05	0.000506	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CYP2B6—malignant glioma	1.44e-05	0.000505	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—GSTP1—malignant glioma	1.43e-05	0.000503	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CYP2C18—malignant glioma	1.42e-05	0.0005	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CAV1—malignant glioma	1.42e-05	0.000498	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	1.41e-05	0.000496	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—KDR—malignant glioma	1.4e-05	0.000493	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—FN1—malignant glioma	1.4e-05	0.000493	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—F2—malignant glioma	1.4e-05	0.000493	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of proteins—CXCL8—malignant glioma	1.39e-05	0.00049	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—CAT—malignant glioma	1.39e-05	0.00049	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	1.38e-05	0.000485	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CYP2B6—malignant glioma	1.35e-05	0.000476	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—F2—malignant glioma	1.35e-05	0.000474	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—FN1—malignant glioma	1.35e-05	0.000474	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—PIK3CG—malignant glioma	1.34e-05	0.000472	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.34e-05	0.000471	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—BAD—malignant glioma	1.33e-05	0.000469	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—EGF—malignant glioma	1.33e-05	0.000466	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—NOTCH1—malignant glioma	1.32e-05	0.000464	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—PTPN11—malignant glioma	1.32e-05	0.000463	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—NCOR1—malignant glioma	1.31e-05	0.000462	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—IDH1—malignant glioma	1.31e-05	0.000462	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	1.31e-05	0.000462	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	1.3e-05	0.000458	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CD80—malignant glioma	1.29e-05	0.000455	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—APC—malignant glioma	1.29e-05	0.000454	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—PIK3CG—malignant glioma	1.29e-05	0.000454	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—EGF—malignant glioma	1.28e-05	0.000449	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—SPHK1—malignant glioma	1.27e-05	0.000447	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—PTPN11—malignant glioma	1.27e-05	0.000446	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CYP2C18—malignant glioma	1.25e-05	0.000438	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ASMT—malignant glioma	1.24e-05	0.000437	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—IDH1—malignant glioma	1.24e-05	0.000435	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—AKT2—malignant glioma	1.23e-05	0.000431	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—CAV1—malignant glioma	1.22e-05	0.00043	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.22e-05	0.000429	CbGpPWpGaD
Mirabegron—ALB—Platelet activation, signaling and aggregation—PIK3CA—malignant glioma	1.22e-05	0.000427	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—BRAF—malignant glioma	1.21e-05	0.000427	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—SPHK1—malignant glioma	1.2e-05	0.000421	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	1.2e-05	0.000421	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—AKT2—malignant glioma	1.18e-05	0.000415	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—PIK3CD—malignant glioma	1.18e-05	0.000415	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.18e-05	0.000414	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—EGFR—malignant glioma	1.18e-05	0.000414	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CYP2C18—malignant glioma	1.17e-05	0.000413	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—BCAN—malignant glioma	1.17e-05	0.000411	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.17e-05	0.00041	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	1.16e-05	0.000407	CbGpPWpGaD
Mirabegron—ALB—Metabolism—GSTT1—malignant glioma	1.15e-05	0.000404	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—PIK3CD—malignant glioma	1.13e-05	0.000399	CbGpPWpGaD
Mirabegron—ADRB3—GPCR downstream signaling—PIK3CA—malignant glioma	1.12e-05	0.000395	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PIK3CG—malignant glioma	1.11e-05	0.000391	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—KRAS—malignant glioma	1.11e-05	0.000391	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—FGF2—malignant glioma	1.09e-05	0.000382	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PTGS1—malignant glioma	1.08e-05	0.000379	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PPARG—malignant glioma	1.07e-05	0.000378	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.07e-05	0.000377	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—CAV1—malignant glioma	1.07e-05	0.000377	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—RAF1—malignant glioma	1.05e-05	0.00037	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—PIK3CB—malignant glioma	1.03e-05	0.000361	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.02e-05	0.00036	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—PIK3CA—malignant glioma	1.02e-05	0.000359	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—MDM2—malignant glioma	1.02e-05	0.000357	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—RAF1—malignant glioma	1.01e-05	0.000356	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GSTT1—malignant glioma	1.01e-05	0.000354	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—ERBB2—malignant glioma	1e-05	0.000352	CbGpPWpGaD
Mirabegron—ALB—Metabolism—BCHE—malignant glioma	1e-05	0.000352	CbGpPWpGaD
Mirabegron—ALB—Platelet activation, signaling and aggregation—AKT1—malignant glioma	9.93e-06	0.000349	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—PIK3CB—malignant glioma	9.89e-06	0.000348	CbGpPWpGaD
Mirabegron—ALB—Metabolism—SLC5A5—malignant glioma	9.89e-06	0.000348	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PIK3CD—malignant glioma	9.78e-06	0.000344	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	9.77e-06	0.000344	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PIK3CG—malignant glioma	9.76e-06	0.000343	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CXCL8—malignant glioma	9.51e-06	0.000334	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GSTT1—malignant glioma	9.49e-06	0.000334	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PTGS1—malignant glioma	9.44e-06	0.000332	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—IL2—malignant glioma	9.44e-06	0.000332	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PPARG—malignant glioma	9.42e-06	0.000331	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—IDH2—malignant glioma	9.41e-06	0.000331	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	9.35e-06	0.000329	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	9.27e-06	0.000326	CbGpPWpGaD
Mirabegron—ADRB3—GPCR downstream signaling—AKT1—malignant glioma	9.18e-06	0.000323	CbGpPWpGaD
Mirabegron—ALB—Transmembrane transport of small molecules—RAF1—malignant glioma	9.11e-06	0.00032	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CASP3—malignant glioma	9.1e-06	0.00032	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—IL2—malignant glioma	9.08e-06	0.000319	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PTGS1—malignant glioma	8.89e-06	0.000313	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CYP2B6—malignant glioma	8.85e-06	0.000311	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—BCHE—malignant glioma	8.77e-06	0.000309	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—SLC5A5—malignant glioma	8.67e-06	0.000305	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—MMP9—malignant glioma	8.6e-06	0.000302	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PIK3CD—malignant glioma	8.58e-06	0.000302	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—PTEN—malignant glioma	8.55e-06	0.000301	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PIK3CB—malignant glioma	8.53e-06	0.0003	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PTGS2—malignant glioma	8.45e-06	0.000297	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—AKT1—malignant glioma	8.34e-06	0.000293	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—BCHE—malignant glioma	8.27e-06	0.000291	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—SLC5A5—malignant glioma	8.17e-06	0.000287	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—IDH1—malignant glioma	8.09e-06	0.000285	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	8.08e-06	0.000284	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—VEGFA—malignant glioma	8.02e-06	0.000282	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	7.98e-06	0.000281	CbGpPWpGaD
Mirabegron—ALB—Metabolism—GSTP1—malignant glioma	7.97e-06	0.00028	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—SPHK1—malignant glioma	7.83e-06	0.000275	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CAT—malignant glioma	7.75e-06	0.000273	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—VEGFA—malignant glioma	7.72e-06	0.000271	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CYP2C18—malignant glioma	7.67e-06	0.00027	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—STAT3—malignant glioma	7.64e-06	0.000269	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PIK3CB—malignant glioma	7.48e-06	0.000263	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PTGS2—malignant glioma	7.41e-06	0.000261	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PTEN—malignant glioma	7.37e-06	0.000259	CbGpPWpGaD
Mirabegron—ALB—Metabolism—NCOR1—malignant glioma	7.32e-06	0.000257	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—MYC—malignant glioma	7.1e-06	0.00025	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GSTP1—malignant glioma	6.98e-06	0.000245	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—EGFR—malignant glioma	6.95e-06	0.000244	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—KRAS—malignant glioma	6.82e-06	0.00024	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CAT—malignant glioma	6.79e-06	0.000239	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GSTP1—malignant glioma	6.58e-06	0.000231	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—KRAS—malignant glioma	6.56e-06	0.000231	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PTEN—malignant glioma	6.46e-06	0.000227	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—NCOR1—malignant glioma	6.42e-06	0.000226	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CAT—malignant glioma	6.4e-06	0.000225	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—PIK3CA—malignant glioma	6.26e-06	0.00022	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GSTT1—malignant glioma	6.21e-06	0.000218	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—TP53—malignant glioma	6.06e-06	0.000213	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—NCOR1—malignant glioma	6.05e-06	0.000213	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—PIK3CA—malignant glioma	6.03e-06	0.000212	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CAV1—malignant glioma	5.97e-06	0.00021	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—TP53—malignant glioma	5.83e-06	0.000205	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PTGS1—malignant glioma	5.81e-06	0.000204	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.7e-06	0.000201	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PIK3CG—malignant glioma	5.44e-06	0.000191	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—BCHE—malignant glioma	5.41e-06	0.00019	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—SLC5A5—malignant glioma	5.34e-06	0.000188	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PPARG—malignant glioma	5.25e-06	0.000185	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CAV1—malignant glioma	5.23e-06	0.000184	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PIK3CA—malignant glioma	5.2e-06	0.000183	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—AKT1—malignant glioma	5.12e-06	0.00018	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CAV1—malignant glioma	4.93e-06	0.000173	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—AKT1—malignant glioma	4.93e-06	0.000173	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PIK3CD—malignant glioma	4.78e-06	0.000168	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PIK3CG—malignant glioma	4.76e-06	0.000168	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PPARG—malignant glioma	4.6e-06	0.000162	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PIK3CA—malignant glioma	4.56e-06	0.00016	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PIK3CG—malignant glioma	4.49e-06	0.000158	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PPARG—malignant glioma	4.33e-06	0.000152	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GSTP1—malignant glioma	4.3e-06	0.000151	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—AKT1—malignant glioma	4.25e-06	0.000149	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PIK3CD—malignant glioma	4.19e-06	0.000147	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CAT—malignant glioma	4.19e-06	0.000147	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PIK3CB—malignant glioma	4.17e-06	0.000146	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PTGS2—malignant glioma	4.13e-06	0.000145	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—NCOR1—malignant glioma	3.95e-06	0.000139	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PIK3CD—malignant glioma	3.95e-06	0.000139	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—AKT1—malignant glioma	3.73e-06	0.000131	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PIK3CB—malignant glioma	3.65e-06	0.000128	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PTGS2—malignant glioma	3.62e-06	0.000127	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PTEN—malignant glioma	3.6e-06	0.000127	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PIK3CB—malignant glioma	3.44e-06	0.000121	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PTGS2—malignant glioma	3.41e-06	0.00012	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CAV1—malignant glioma	3.22e-06	0.000113	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PTEN—malignant glioma	3.15e-06	0.000111	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PTEN—malignant glioma	2.97e-06	0.000105	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PIK3CG—malignant glioma	2.93e-06	0.000103	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PPARG—malignant glioma	2.83e-06	9.96e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PIK3CD—malignant glioma	2.58e-06	9.07e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PIK3CA—malignant glioma	2.54e-06	8.93e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PIK3CB—malignant glioma	2.25e-06	7.91e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PTGS2—malignant glioma	2.23e-06	7.84e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PIK3CA—malignant glioma	2.23e-06	7.82e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PIK3CA—malignant glioma	2.1e-06	7.37e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—AKT1—malignant glioma	2.07e-06	7.29e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PTEN—malignant glioma	1.94e-06	6.83e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—AKT1—malignant glioma	1.82e-06	6.39e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—AKT1—malignant glioma	1.71e-06	6.02e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.37e-06	4.82e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—AKT1—malignant glioma	1.12e-06	3.94e-05	CbGpPWpGaD
